Thermo Fisher Agrees to Buy Alfa Aesar for $403M

News Jun 26, 2015

The deal is expected to be completed by the end of 2015 and will be integrated into Thermo Fisher's Laboratory Products and Services segment.

Based in Heysham, UK, Alfa Aesar is part of Johnson Matthey and has 480 employees. Among its product offerings are chemicals for DNA-, RNA-, and PCR-based research, products for DNA and protein labeling, and proteomics reagents and kits.

Also, Alfa Aesar offers immunology products, antibodies, cell culture reagents, and other technologies.

The firm operates in the US, Germany, China, South Korea, and India and generated £78 million in sales in 2014.

Thermo Fisher President and CEO Marc Casper said the acquisition enhances his firm's existing portfolio of chemicals, solvents, and reagents "to support virtually every laboratory application".

Bacterial ‘Sleeper Cells’ Evade Antibiotics and Weaken Defence Against Infection

News

These bacteria persister cells stop replicating and can remain in this dormant, ‘sleeper-cell’ state for days, weeks or even months. When antibiotic treatment has been stopped, if some of these bacterial cells spring back to life, they can trigger another infection.

Multigene Test Facilitates Targeted Use of Chemotherapy for Breast Cancer

News

New results show that the multigene test used at the university hospital in Munich is indeed helpful in making more targeted use of chemotherapy treatments and thus improves prognosis of breast cancer patients.